Sell Dr. Reddy's Laboratories, target Rs 2375: Dr CK Narayan
Sell Dr. Reddy's Laboratories Ltd. at a price target of Rs 2375.0 and a stoploss at Rs 2436 from entry point.

Dr. Reddy's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9586.80 Crore to Sales Value (98.63 % of Total Sales), Other Operating Revenue which contributed Rs 50.40 Crore to Sales Value (0.51 % of Total Sales), Licence Fees which contributed Rs 41.30 Crore to Sales Value (0.42 % of Total Sales), Scrap which contributed Rs 20.70 Crore to Sales Value (0.21 % of Total Sales) and Spent Chemicals which contributed Rs 20.60 Crore to Sales Value (0.21 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 30-09-2018, the company has reported a Consolidated sales of Rs 3686.60 Crore, up .98 % from last quarter Sales of Rs 3650.70 Crore and up 3.97 % from last year same quarter Sales of Rs 3546.00 Crore Company has reported net profit after tax of Rs 507.40 Crore in latest quarter. The company’s top management includes Dr.Ashok S Ganguly, Dr.Bruce L A Carter, Dr.Omkar Goswami, Mr.Anupam Puri, Mr.Bharat N Doshi, Mr.G V Prasad, Mr.K Satish Reddy, Mr.Leo Puri, Mr.Sridar Iyengar, Ms.Kalpana Morparia. Company has S R Batliboi & Associates LLP as its auditoRs As on 30-09-2018, the company has a total of 166,045,857 shares outstanding.
Download ET Markets APP